Cardiac hypertrophy and altered hemodynamic adaptation in growth-restricted preterm infants

Jaana A Leipälä1, Talvikki Boldt, Ursula Turpeinen

  • 1Hospital for Children and Adolescents, University of Helsinki, Finland. jaana.leipala@kcl.ac.uk

Pediatric Research
|March 7, 2003
PubMed

Insights

Very low birth weight infants with intrauterine growth restriction show cardiac adaptation issues. These small for gestational age (SGA) infants have higher initial cardiac output and impaired blood volume regulation, increasing circulatory failure risk.

Area of Science:

  • Neonatal Physiology
  • Cardiovascular Adaptation
  • Perinatal Medicine

Background:

  • Intrauterine growth restriction (IUGR) affects fetal development, potentially impacting neonatal adaptation.
  • Hemodynamic changes in preterm infants require careful monitoring for optimal outcomes.

Purpose of the Study:

  • To investigate the hemodynamic adaptation in very low birth weight infants with IUGR.
  • To compare cardiovascular parameters between small for gestational age (SGA) and appropriate for gestational age (AGA) infants.

Main Methods:

  • Echocardiographic assessment of cardiac dimensions and left ventricular output (LVO).
  • Measurement of serum brain natriuretic peptide (BNP) levels.
  • Assessment of red cell volume (RCV) and blood volume (BV) post-transfusion.

Main Results:

  • SGA infants exhibited increased interventricular septum and left ventricle diastolic diameters, and elevated BNP.
  • SGA infants presented higher initial LVO compared to AGA infants, with no further increase observed.
  • AGA infants showed significant increases in RCV and BV, surpassing SGA infants by day 3.

Conclusions:

  • Cardiac hypertrophy and elevated initial LVO in SGA infants suggest increased cardiac workload post-IUGR.
  • Impaired blood volume regulation may contribute to the challenges faced by SGA infants.
  • SGA preterm infants are at a higher risk of circulatory failure during early adaptation.

Related Concept Videos

Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...